Bio-X Compounds / Information Center
Research compounds.
Knowledge with clarity.
Explore the information behind the Bio-X Compounds catalog. Understand compound names, recognize product codes, and make sense of analytical documentation within a clear laboratory research context.
For laboratory research use only.
Not for human or veterinary use.
The Bio-X approach
Trust begins
with clear information.
Quality deserves more than a label. Meaningful evaluation starts with clear identification, relevant documentation, and an honest explanation of what the evidence supports. These principles guide this information center.
Know what you
are reviewing.
Compound names and catalog codes should connect clearly. Identification provides the starting point for comparing a research material with its stated specifications and corresponding documentation.
Look beyond
a quality claim.
Evaluate the specific batch, the analytical method, and the reported result. Purity, quantity, identity, and sterility are distinct properties; evidence for one does not automatically establish the others.
Understand what
the evidence means.
Useful information explains both findings and limitations. Research references and analytical reports should be read in context, without treating them as guarantees of safety or clinical suitability.
Bio-X Compounds Info is the educational and documentation center for Bio-X Compounds. Content is provided for informational purposes and does not constitute medical advice or instructions for human or veterinary use.
Explore the research library / Semaglutide
Semaglutide research.
Understand BXC-1SM.
Semaglutide is a modified glucagon-like peptide-1 (GLP-1) analogue that acts as a GLP-1 receptor agonist. Its molecular design has been investigated through studies of receptor activity, albumin binding, and resistance to enzymatic degradation.
In the Bio-X Compounds catalog, Semaglutide is identified as BXC-1SM. The COA naming is Semaglutide (BXC-1SM), connecting the compound name with the catalog identifier.
Start with the scientific background, then distinguish general findings about Semaglutide from the specifications and analytical results associated with an individual research batch.
What is Semaglutide?
Semaglutide is a GLP-1 analogue with structural modifications investigated for their effects on receptor activity and molecular persistence. The dedicated guide introduces the published research behind its design.
Why the name BXC-1SM?
BXC-1SM is the identifier used for Semaglutide in the Bio-X Compounds catalog. Use this code to locate the listing, then compare its stated specifications with the relevant documentation.
Read the matching COA.
Match the compound and lot number before interpreting results. A purity result does not independently establish vial content, sterility, or safety; each property requires appropriate supporting evidence.
Scientific reference: Lau et al., 2015. Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide. Journal of Medicinal Chemistry. Published findings do not verify the identity or performance of a Bio-X batch.
Laboratory research context: The BXC-1SM research material is not a finished prescription medicine or a substitute for one. Not for human or veterinary use. This information does not provide medical advice, dosing, or administration instructions.
Explore the research library / Tesamorelin
Tesamorelin research.
Explore BXC-TESA.
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH), also called growth hormone-releasing factor (GRF). Its pharmacology involves GHRH receptor activation and the regulation of endogenous growth hormone release.
In the Bio-X Compounds catalog, Tesamorelin is identified as BXC-TESA. This reference connects the compound name with the catalog code while keeping scientific background distinct from batch-specific analytical findings.
Explore the relationship between Tesamorelin, GHRH receptors, growth hormone, and IGF-1. Understanding these terms provides context for reading the literature without assuming that published findings verify a particular research material or establish its suitability for an application.
What is Tesamorelin?
Tesamorelin is a synthetic GHRH analogue. Its interaction with the GHRH receptor connects it to the biological systems involved in growth hormone synthesis and release.
GHRH, GH, and IGF-1.
GHRH, growth hormone, and IGF-1 occupy different positions in an interconnected signaling system. Tesamorelin is a GHRH analogue; it is not growth hormone or IGF-1 itself.
Evaluate the specific batch.
Review the compound identity, lot reference, testing methods, and reported results. General literature does not establish the purity, content, sterility, or activity of an individual vial.
Scientific reference: DailyMed: EGRIFTA SV prescribing information, Description and Clinical Pharmacology. This source concerns a prescription formulation. It does not verify or endorse BXC-TESA.
Laboratory research context: BXC-TESA is presented as a research material, not a finished prescription medicine or a substitute for one. Not for human or veterinary use. No dosing or administration instructions are provided.
Explore the research library / SS-31
SS-31 research.
Explore BXC-31.
SS-31 is a synthetic tetrapeptide studied for its interactions with cardiolipin, a phospholipid associated with the inner mitochondrial membrane. Published experimental work examines its relationship with cytochrome c, electron transport, and mitochondrial energy production.
In the Bio-X Compounds catalog, SS-31 is identified as BXC-31. This reference connects the compound name with the catalog listing and introduces the scientific terminology used in mitochondrial peptide research.
Explore the research behind SS-31, cardiolipin interactions, mitochondrial respiration, and ATP synthesis. Interpret each finding within the experimental model studied, keeping published results separate from claims about a specific research batch.
What is SS-31?
SS-31 is a four-residue synthetic peptide investigated in mitochondrial research. Its interactions with cardiolipin provide a focus for studies of membrane organization and mitochondrial function.
Read the model behind the result.
Studies of membrane preparations and experimental models examine cytochrome c activity, oxygen consumption, and ATP synthesis. Results depend on the methods, conditions, and biological systems investigated.
Connect identity with evidence.
Use BXC-31 to locate the catalog listing, then match the compound and lot number to the relevant report. Identity, purity, content, and biological activity require appropriate supporting evidence.
Scientific reference: Birk et al., 2013. The Mitochondrial-Targeted Compound SS-31 Re-Energizes Ischemic Mitochondria by Interacting with Cardiolipin. Published research does not verify or endorse BXC-31 or an individual Bio-X batch.
Laboratory research context: BXC-31 is presented as a laboratory research material. Not for human or veterinary use. This content does not provide medical advice, dosing, administration instructions, or guarantees of therapeutic benefit.